title: Hypoxia downregulates p53 but induces apoptosis and enhances expression of BAD in cultures of human syncytiotrophoblasts.
abstract: Hypoxia is commonly assigned a role in the placental dysfunction characteristic of preeclampsia and intrauterine growth restriction. We previously showed that hypoxia upregulates p53 and enhances apoptosis in primary cultures of human cytotrophoblasts. Here we tested the hypothesis that hypoxia also induces apoptosis in syncytiotrophoblasts by upregulation of p53. Primary cultures of human cytotrophoblasts that had differentiated into syncytiotrophoblasts by 52 h were exposed for ≤24 h to 20% or <1% oxygen in the presence or absence of staurosporine or the p53 modulators nutlin-3, pifithrin-α, and pifithrin-μ. Proteins were detected by Western blot analysis or immunofluorescence. Compared with 20% oxygen, exposure of syncytiotrophoblasts to <1% oxygen upregulated hypoxia-inducible factor (HIF)-1α and rapidly downregulated p53. Activity of p53 in hypoxic syncytiotrophoblasts was reduced by the higher expression of the negative p53 regulator MDMX and by the reduction of phosphorylation of p53 at Ser(392), which reduces p53 activity. Conversely, staurosporine, a kinase inhibitor, and nutlin-3, a drug that enhances p53 expression, both raised p53 levels and increased the rate of apoptosis in syncytiotrophoblasts compared with vehicle controls. Immunofluorescence staining showed p53 immunolocalized to both cytoplasm and nuclei of nutlin-3-exposed syncytiotrophoblasts. The hypoxia-induced apoptosis in syncytiotrophoblasts correlated with enhanced expression of the proapoptotic BAD and a reduced level of antiapoptotic BAD phosphorylated on Ser(112). We surmise that cell death induced by extreme hypoxia in syncytiotrophoblasts follows a non-p53-dependent pathway, unlike that of a nonhypoxic stimulus and unlike hypoxic cytotrophoblasts. We speculate that downregulation of p53 activity in response to hypoxia reduces or eliminates the apoptosis transduced by the p53 pathway in syncytiotrophoblasts, thereby limiting cell death and maintaining the integrity of this critical villous component.
authors.affiliation: Department of Obstetrics and Gynecology, Washington University School of Medicine, St. Louis, Missouri 63110, USA.
authors.forename: Baosheng
authors.initials: B
authors.lastname: Chen
authors.forename: Mark S
authors.initials: MS
authors.lastname: Longtine
authors.forename: Yoel
authors.initials: Y
authors.lastname: Sadovsky
authors.forename: D Michael
authors.initials: DM
authors.lastname: Nelson
mesh_terms: D000818:Animals; D017209:Apoptosis / Q000502:physiology*; D052160:Benzothiazoles / Q000494:pharmacology; D002478:Cells, Cultured; D015536:Down-Regulation; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005260:Female; D005786:Gene Expression Regulation; D006801:Humans; D000860:Hypoxia / Q000378:metabolism*; D007093:Imidazoles / Q000494:pharmacology; D010100:Oxygen / Q000378:metabolism; D010879:Piperazines / Q000494:pharmacology; D011247:Pregnancy; D019311:Staurosporine / Q000494:pharmacology; D014050:Toluene / Q000031:analogs & derivatives / Q000494:pharmacology; D014327:Trophoblasts / Q000166:cytology / Q000187:drug effects / Q000502:physiology*; D016159:Tumor Suppressor Protein p53 / Q000235:genetics / Q000378:metabolism*; D051025:bcl-Associated Death Protein / Q000235:genetics / Q000378:metabolism*
chemical_list: D052160:Benzothiazoles; D004791:Enzyme Inhibitors; D007093:Imidazoles; D010879:Piperazines; D016159:Tumor Suppressor Protein p53; D051025:bcl-Associated Death Protein; D014050:Toluene; C482205:nutlin 3; C121565:pifithrin; D019311:Staurosporine; D010100:Oxygen
references.citation: Cancer Res. 2000 Oct 15;60(20):5630-4
references.pmid: 11059752
references.citation: J Biol Chem. 2010 Jan 22;285(4):2601-9
references.pmid: 19880525
references.citation: Br Med J (Clin Res Ed). 1987 Apr 25;294(6579):1051-3
references.pmid: 3107690
references.citation: Cancer Res. 2007 Sep 15;67(18):8810-7
references.pmid: 17875722
references.citation: Am J Obstet Gynecol. 2004 Aug;191(2):563-71
references.pmid: 15343238
references.citation: Neoplasia. 2008 Jun;10(6):587-96
references.pmid: 18516295
references.citation: J Biol Chem. 2003 May 2;278(18):15465-8
references.pmid: 12637507
references.citation: Cell Death Differ. 2006 Jun;13(6):927-34
references.pmid: 16543935
references.citation: J Biol Chem. 2006 Feb 3;281(5):2764-72
references.pmid: 16314423
references.citation: Proc Natl Acad Sci U S A. 2007 Mar 6;104(10):4054-9
references.pmid: 17360476
references.citation: Proc Natl Acad Sci U S A. 2002 Jan 8;99(1):95-100
references.pmid: 11756653
references.citation: Biochemistry. 1997 Aug 19;36(33):10117-24
references.pmid: 9254608
references.citation: Cell. 1996 Nov 15;87(4):619-28
references.pmid: 8929531
references.citation: Development. 1991 Nov;113(3):767-77
references.pmid: 1821848
references.citation: Proc Natl Acad Sci U S A. 2002 Aug 6;99(16):10305-9
references.pmid: 12124396
references.citation: J Biol Chem. 2009 Mar 27;284(13):8812-21
references.pmid: 19153082
references.citation: J Biol Chem. 2003 Apr 18;278(16):13595-8
references.pmid: 12606552
references.citation: Placenta. 2008 Sep;29(9):772-83
references.pmid: 18706691
references.citation: Am J Physiol Cell Physiol. 2000 May;278(5):C982-8
references.pmid: 10794672
references.citation: Mol Hum Reprod. 2007 Feb;13(2):111-6
references.pmid: 17158854
references.citation: Am J Pathol. 2007 Aug;171(2):496-506
references.pmid: 17600131
references.citation: Science. 2004 Feb 6;303(5659):844-8
references.pmid: 14704432
references.citation: J Pathol. 2010 Jan;220(2):164-73
references.pmid: 19918835
references.citation: N Engl J Med. 1993 Mar 11;328(10):692-6
references.pmid: 8433728
references.citation: Am J Obstet Gynecol. 2002 May;186(5):1056-61
references.pmid: 12015537
references.citation: Endocrinology. 2008 May;149(5):2131-7
references.pmid: 18276761
references.citation: Mol Cell. 2001 Feb;7(2):283-92
references.pmid: 11239457
references.citation: Placenta. 2009 Jun;30(6):473-82
references.pmid: 19375795
references.citation: Biochem Biophys Res Commun. 2005 Jun 10;331(3):750-60
references.pmid: 15865931
references.citation: Endocrinology. 1986 Apr;118(4):1567-82
references.pmid: 3512258
references.citation: J Cell Mol Med. 2004 Oct-Dec;8(4):423-31
references.pmid: 15601571
references.citation: Placenta. 2006 Sep-Oct;27(9-10):978-83
references.pmid: 16376985
references.citation: Carcinogenesis. 2006 Mar;27(3):656-63
references.pmid: 16258175
references.citation: Respir Physiol. 1995 May;100(2):101-6
references.pmid: 7624611
references.citation: Cell Death Differ. 2010 Jan;17(1):86-92
references.pmid: 19543236
references.citation: Blood. 2008 Nov 1;112(9):3827-34
references.pmid: 18682598
references.citation: Am J Obstet Gynecol. 2001 Apr;184(5):998-1003
references.pmid: 11303211
references.citation: Curr Mol Med. 2004 Nov;4(7):741-51
references.pmid: 15579021
references.citation: Cell Prolif. 2005 Aug;38(4):257-67
references.pmid: 16098184
references.citation: Trends Cell Biol. 2010 May;20(5):299-309
references.pmid: 20172729
references.citation: Nat Rev Cancer. 2009 Oct;9(10):691-700
references.pmid: 19759539
references.citation: Am J Pathol. 2007 May;170(5):1511-20
references.pmid: 17456758
references.citation: Am J Obstet Gynecol. 1999 Apr;180(4):896-902
references.pmid: 10203658
references.citation: Mol Cell. 2001 Mar;7(3):683-94
references.pmid: 11463392
references.citation: Science. 2003 Nov 7;302(5647):1036-8
references.pmid: 14500851
references.citation: Nature. 1997 May 15;387(6630):296-9
references.pmid: 9153395
references.citation: Nat Chem Biol. 2006 Sep;2(9):474-9
references.pmid: 16862141
references.citation: Placenta. 2001 Nov;22(10):822-30
references.pmid: 11718569
references.citation: Cell. 2009 May 15;137(4):609-22
references.pmid: 19450511
references.citation: Placenta. 2009 Mar;30 Suppl A:S43-8
references.pmid: 19081132